We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants

20 hedge funds and large institutions have $3.03M invested in Japer Therapeutics Warrants in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $2.51M → $3.03M (+$524K)

23% less funds holding

Funds holding: 2620 (-6)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
20
Holders Change
-6
Holders Change %
-23.08%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$773K
TCM
2
Tenor Capital Management
New York
$288K
PSAMP
3
P. Schoenfeld Asset Management (PSAM)
New York
$273K
SCM
4
Shaolin Capital Management
Florida
$229K +$23.3K +24,566 +14%
SRCM
5
Sage Rock Capital Management
New York
$220K
AA
6
AQR Arbitrage
Connecticut
$218K
UOC
7
UBS O'Connor
Illinois
$208K
GCL
8
Glazer Capital LLC
New York
$187K -$4.64K -4,900 -3%
MS
9
Maven Securities
Jersey
$116K
BI
10
Bulldog Investors
New Jersey
$105K
MIM
11
Monashee Investment Management
Massachusetts
$101K
RCM
12
Rivernorth Capital Management
Florida
$76K
HF
13
HRT Financial
New York
$70K +$19.2K +20,276 +50%
LA
14
Linden Advisors
New York
$38K -$29.6K -31,243 -49%
CAC
15
Cowen and Company
New York
$35K +$28.4K +30,000 New
YCM
16
Yakira Capital Management
Connecticut
$29K -$11.6K -12,266 -32%
CCM
17
Context Capital Management
California
$29K
CAPTRUST Financial Advisors
18
CAPTRUST Financial Advisors
North Carolina
$26K -$1.9K -2,000 -8%
EIP
19
Easterly Investment Partners
Massachusetts
$12K
KJHP
20
K.J. Harrison & Partners
Ontario, Canada
$12
PMAM
21
Picton Mahoney Asset Management
Ontario, Canada
-$153K -187,500 Closed
ACM
22
Altium Capital Management
New York
-$133K -162,500 Closed
AGM
23
Alpine Global Management
New York
-$42K -51,000 Closed
OAC
24
OMERS Administration Corp
Ontario, Canada
-$17K -21,300 Closed
ES
25
Equitec Specialists
Illinois
-$11K -13,536 Closed

JSPRW Hedge Fund Activity: Q2 2021 in Review

20 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q2 2021, worth a combined $3.03M — up 21% from $2.51M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of JSPRW and 1 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Cowen and Company, opening a new position worth an estimated $28.4K. The largest seller was Picton Mahoney Asset Management, exiting entirely with an estimated $153K sold.

  • 20 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q2 2021, down from 26 in Q1 2021.
  • Funds reported $3.03M of Japer Therapeutics Warrants stock for Q2 2021, up 21% quarter-over-quarter.
  • 1 fund opened new Japer Therapeutics Warrants positions in Q2 2021 and 7 closed out, a net change of -6 holders.
  • The largest Japer Therapeutics Warrants buyer in Q2 2021 was Cowen and Company, an estimated $28.4K added.
  • The largest Japer Therapeutics Warrants seller in Q2 2021 was Picton Mahoney Asset Management, an estimated $153K sold.

Based on aggregated 13F filings for Q2 2021.